Mineralys Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & Equivalents | $172.9M | $114.1M | $49.3M | $87.7M |
| Accounts Receivable | — | — | — | — |
| Inventory | — | — | — | — |
| Total Current Assets | $661.4M | $205.4M | $249.1M | $112.8M |
| Property, Plant & Equipment | $38.0K | $53.0K | $0 | — |
| Goodwill | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — |
| Total Assets | $661.8M | $205.9M | $251.6M | $114.4M |
| Liabilities | ||||
| Accounts Payable | $2.0M | $479.0K | $601.0K | $1.9M |
| Total Current Liabilities | $15.1M | $14.6M | $10.5M | $8.1M |
| Long-Term Debt | — | — | — | — |
| Total Liabilities | $15.1M | $14.6M | $10.5M | $166.7M |
| Stockholders' Equity | ||||
| Retained Earnings | $-457.2M | $-302.5M | $-124.7M | $-52.8M |
| Total Stockholders' Equity | $646.7M | $191.3M | $241.2M | $-52.3M |